Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial is a research paper published in The Journal of Infectious Diseases (2022). On theSindex it has a DataRank of 0.686. It has been cited 21 times, with 10 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0.222
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 10 citers.
for Preparedness and Response, Biomedical Advanced Research and Development Authority
Grant: 75A50120C00034
HVTN
Grant: UM1 AI 68614HVTN
Statistics and Data Management Center
Grant: UM1 AI 68635
HVTN Laboratory Center
Grant: UM1 AI 68618
HIV Prevention Trials Network Leadership and Operations Center
Grant: UM1 AI 68619
AIDS Clinical Trials Group Leadership and Operations Center
Grant: UM1 AI 68636
Infectious Diseases Clinical Research Consortium
Grant: UM1 AI148684-03
NIAID NIH HHS
Grant: UM1 AI068614
NIAID NIH HHS
Grant: UM1 AI068619
NCATS NIH HHS
Grant: UL1 TR002384
NIAID NIH HHS
Grant: UM1 AI068618
NIAID NIH HHS
Grant: UM1 AI069412
NIAID NIH HHS
Grant: UM1 AI148575
NIAID NIH HHS
Grant: UM1 AI068617
NIAID NIH HHS
Grant: S10 AI174104
NIAID NIH HHS
Grant: UM1 AI148684
NIAID NIH HHS
Grant: UM1 AI068635
NIAID NIH HHS
Grant: UM1 AI068636
HIV Vaccine Trials Network
NIAID
Office of the Assistant Secretary
MeSH Terms
Keywords